References
- Public Health Agency of Canada. Interactive data visualizations of COVID-19 [Internet]. 2022. https://health-infobase.canada.ca/covid-19/international/. Accessed November 2022.
- Sadhu S, Agrawal R, Pyare R, et al. Covid-19: limiting the risks for eye care professionals. Ocul Immunol Inflamm. 2020;28(5):714–720. doi:10.1080/09273948.2020.1755442.
- Lawrenson JG, Buckley RJ. Covid-19 and the eye. Ophthalmic Physiol Opt. 2020;40(4):383–388. doi:10.1111/opo.12708.
- Domínguez-Varela IA, Rodríguez-Gutiérrez LA, Morales-Mancillas NR, Barrera-Sánchez M, Macías-Rodríguez Y, Valdez-García JE. Covid-19 and the eye: a review. Infect Dis (Auckl). 2021;53(6):399–403. doi:10.1080/23744235.2021.1882697.
- Schnichels S, Rohrbach JM, Bayyoud T, Thaler S, Ziemssen F, Hurst J. Can SARS-CoV-2 infect the eye? An overview of the receptor status in ocular tissue. Ophthalmologe. January, 2021;118(Suppl 1):81–84. doi:10.1007/s00347-020-01281-5. PMID: 33289868; PMCID: PMC7722245.
- de Freitas Santoro D, de Sousa LB, Camara NOS, de Freitas D, de Oliveira LA. SARS-COV-2 and ocular surface: from physiology to pathology, a route to understand transmission and disease. Front Physiol. February 12, 2021;12(9):612319. doi:10.3389/fphys.2021.612319. PMID: 33643063; PMCID: PMC7907452.
- Sasamoto Y, Lee CAA, Yoshihara M, et al. High expression of SARS-CoV2 viral entry-related proteins in human limbal stem cells. Ocul Surf. January, 2022;23:197–200. doi:10.1016/j.jtos.2021.10.002. Epub 2021 Oct 13. PMID: 34653711; PMCID: PMC8511872.
- Mahmoud H, Ammar H, El Rashidy A, Ali AH, Hefny HM, Mounir A. Assessment of coronavirus in the conjunctival tears and secretions in patients with SARS-CoV-2 infection in Sohag Province, Egypt. Clin Ophthalmol. 2020;14:2701–2708. doi:10.2147/OPTH.S270006.
- Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi:10.1001/jamaophthalmol.2020.1291.
- Arora R, Goel R, Saxena S, et al. Comparative evaluation of tears and nasopharyngeal swab for SARS-CoV-2 in COVID-19 dedicated intensive care unit patients. Ocul Immunol Inflamm. 2021;29(4):690–696. doi:10.1080/09273948.2021.1903938.
- Hadrawi M, Malak M, Almahmoudi F, et al. Testing the sensitivity of conjunctival swabs from confirmed COVID-19 patients. Clin Ophthalmol. 2021;15:2489–2496. doi:10.2147/OPTH.S313721.
- Ranzenigo M, Bruzzesi E, Galli L, et al. Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndrome. J Ophthal Inflamm Infect 11, 35 (2021). doi:10.1186/s12348-021-00264-0.
- Sonmez A, Aydın Kurna S, Aslan FG, et al. SARS-COV-2 viral load in tears of patients with COVID-19 in the early symptomatic stages: comparison of two different tear sampling methods. Int Ophthalmol. 2022;42(8):2425–2438. doi:10.1007/s10792-022-02243-3.
- Güemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A, et al. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis. J Infect. September, 2020;81(3):452–482. doi:10.1016/j.jinf.2020.05.070. Epub 2020 Jun 3. PMID: 32504746; PMCID: PMC7831979.
- Muyldermans A, Bjerke M, Demuyser T, et al. SARS-CoV-2 RNA and antibodies in tear fluid. BMJ Open Ophthalmol 2021;6(1):e000733. doi:10.1136/bmjophth–2021–000733.
- Azzolini C, Donati S, Premi E, et al. SARS-CoV-2 on ocular surfaces in a cohort of patients with COVID-19 from the Lombardy Region, Italy. JAMA Ophthalmol. 2021;139(9):956–963. doi:10.1001/jamaophthalmol.2020.5464.
- Gijs M, Veugen J, Wolffs P, et al. Prevalence of SARS-CoV-2 viral RNA in conjunctival swabs of symptomatic COVID-19 patients in the Netherlands. Invest Ophthalmol Vis Sci. 2021;62(8):1297.
- Ciloglu E, Dogan NC, Ozdemir E, Kaya H, Cetinkaya PD (2021) The presence of SARS-CoV-2 in conjunctival secretions of COVID-19 patients, Ocul Immunol Inflamm, 29(4):652–655. doi:10.1080/09273948.2020.1869270.
- Sehgal G, Bal P, Bal B, Chopra R. Pattern of ocular manifestations and the prevalence of severe acute respiratory syndrome coronavirus-2 in tears of hospitalized coronavirus disease 2019 patients. Taiwan J Ophthalmol. 2021;11(4):380–385. doi:10.4103/tjo.tjo_40_21.
- Meduri A, Oliverio GW, Mancuso G, et al. Ocular surface manifestation of COVID-19 and tear film analysis. Sci Rep. 2020;10(1):20178. doi:10.1038/s41598-020-77194-9.
- Valente P, Iarossi G, Federici M, et al. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report. J AAPOS. 2020;24(4):212–215. doi:10.1016/j.jaapos.2020.05.002.
- Hösel K, von der Burchard C, Schunk D, et al. Ocular manifestations and SARS-CoV-2 analysis in tears in patients with COVID-19. Invest Ophthalmol Vis Sci. 2021;62(8):1988.
- Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival sars-cov-2 in covid-19 patients. Ophthalmology. 2020;127(7):982–983. doi:10.1016/j.ophtha.2020.04.028.
- Karabela Y, Karabela SN, Ozbas M, et al. Investigation of SARS-CoV-2 in tear and conjunctival secretions of hospitalized patients with clinically-confirmed COVID-19 pneumonia. BMC Infect Dis. 2021;21(1):918. doi:10.1186/s12879-021-06630-6.
- Leysen L, Delbeke H, Desmet S, et al. In search of viable sars-cov-2 in the tear film: a prospective clinical study in hospitalized symptomatic patients. Clin Microbiol Infect. 2022;28(8):1172–1173. doi:10.1016/j.cmi.2022.03.026.
- Gasparini MS, Dos Santos LM, Hamade AM, et al. Identification of SARS-CoV-2 on the ocular surface in a cohort of COVID-19 patients from Brazil. Exp Biol Med (Maywood). December, 2021;246(23):2495–2501. doi:10.1177/15353702211024651. Epub 2021 Jul 19. PMID: 34279137; PMCID: PMC8647481.
- Savastano MC, Gambini G, Savastano A, et al. Evidence-based of conjunctival covid-19 positivity: an Italian experience: gemelli against covid group. Eur J Ophthalmol. 2021;31(6):2886–2893. doi:10.1177/1120672120976548.
- Arora R, Goel R, Kumar S, et al. Evaluation of sars-cov-2 in tears of patients with moderate to severe covid-19. Ophthalmology. 2021;128(4):494–503. doi:10.1016/j.ophtha.2020.08.029.
- Kocamış Ö, Örnek K, Aşıkgarip N, Hızmalı L, Sezgin FM, Şahin Y. Evaluation of nasopharyngeal and conjunctival swab samples of hospitalised patients with confirmed COVID-19, Ocul Immunol Inflamm. 2021;29(4):634–637. doi:10.1080/09273948.2020.1838558.
- Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS–CoV–2 infection. J Med Virol. 2020;92(6):589–594. doi:10.1002/jmv.25725.
- Atum M, Boz AAE, Çakır B, et al. Evaluation of conjunctival swab PCR results in patients with SARS-CoV-2 infection, Ocul Immunol Inflamm. 2020;28(5):745–748. doi:10.1080/09273948.2020.1775261.
- Kaur P, Sehgal G, Shailpreet 1, Singh KD1, Singh B. Evaluation and comparison of conjunctival swab polymerase chain reaction results in SARS-CoV-2 patients with and without ocular manifestations. Indian J Ophthalmol. August, 2021;69(8):2211–2214. doi:10.4103/ijo.IJO_587_21.
- Shah A, Laliwala F, Singhal D, Gaidhane A, Khatib N. Documenting ocular findings and conjunctival viral prevalence amongst patients with covid-19 admitted in a tertiary covid care hospital, Ahmedabad. Eur J Mol Clin Med. 2020;7(7):1887–1891.
- Karimi S, Arabi A, Shahraki T, et al. Detection of severe acute respiratory syndrome coronavirus-2 in the tears of patients with coronavirus disease 2019. Eye. 2020;34(7):1220–1223. doi:10.1038/s41433-020-0965-2.
- Chawhan A, Athale A, Khan K, et al. Detection of SARS-CoV-2 RNA in a conjunctival swab sample in real-time-polymerase chain reaction positive COVID-19 patients and its association with comorbidity and severity at a designated COVID-19 hospital in Central India. Indian J Ophthalmol. December, 2021;69(12):3633–3636. doi:10.4103/ijo.IJO_1604_21. PMID: 34827010; PMCID: PMC8837307.
- Misawa MAM, Tanaka T, Braga PGO, et al. Detection of SARS-CoV-2 on conjunctiva by rRT-PCR in patients with severe form of COVID-19. Invest Ophthalmol Vis Sci. 2021;62(8):3461.
- Kaya H, Çalışkan A, Okul M, Sarı T, Akbudak İH. Detection of sars-cov-2 in the tears and conjunctival secretions of coronavirus disease 2019 patients. J Infec Dev Countries. 2020;14(9):977–981. doi:10.3855/jidc.13224.
- Li M, Yang Y, He T, et al. Detection of SARS-CoV-2 in the ocular surface in different phases of COVID-19 patients in Shanghai, China. Ann Transl Med. January, 2021;9(2):100. doi:10.21037/atm-20-6026. PMID: 33569402; PMCID: PMC7867919.
- Yan Y, Zeng B, Zhang Z, et al. Detection of SARS-CoV-2 in simultaneously collected tear and throat swab samples from the patients with 2019- new SARS-CoV-2 infection disease: a single center cross-sectional study, Ophthalmic Epidemiol. 2021;28(5):369–375. doi:10.1080/09286586.2021.1875011.
- Li X, Chan JFW, Li KKW, et al. Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms. Infection. 2021;49(2):257–265. doi:10.1007/s15010-020-01524-2.
- Güemes-Villahoz N, Burgos-Blasco B, Vilela AA, et al. Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19? J Med Virol. 2021;93(1):383–388. doi:10.1002/jmv.26219.
- Lima LCDF, Moraes Junior HV, Moraes HMV. COVID-19 ocular manifestations in the early phase of disease, Ocul Immunol Inflamm. 2021;29(4):666–668. doi:10.1080/09273948.2021.1887278.
- Gunduz A, Firat M, Turkoglu G. Comparison of the simultaneous conjunctiva and oropharynx–nasopharynx swab results in patients applying to the SARS–CoV–2 outpatient clinic for the first time. J Med Virol. 2021;93(7):4516–4522. doi:10.1002/jmv.26981.
- Daryabari SH, Asadollah A, Moghadam FA, et al. Detection of COVID-19 in tears of ICU-admitted patients with SARS-CoV-2 infection. Int Ophthalmol. 2022;42(3):723–727. doi:10.1007/s10792-021-01938-3.
- Ozturk M, Kumova D, Alacam S, et al. Detection of coronavirus in tear samples of hospitalized patients with COVID-19. Int Ophthalmol. 2023;43(2):451–462. doi:10.1007/s10792-022-02442-y.
- Vesely P, Novakova E, Stubna M, et al. Coronavirus disease (covid-19) and conjunctival sac swab findings. J Ophthalmic Inflamm Infect. 2022;12(1). doi:10.1186/s12348-022-00285-3.
- Furdova A, Vesely P, Trnka M, et al. Conjunctival swab findings in 484 COVID-19 patients in four hospital centers in Slovakia. Vision. 2022;6(3):46. doi:10.3390/vision6030046.
- Farzin M, Rasoulinejad SA, Babaei M, et al. Conjunctival polymerase chain reactions in COVID-19 patients and its correlation with clinical and paraclinical indexes. Iran J Microbiol. 2021;13(6):757–763.
- Liu S, Yeung TLM, Tso EYK, Fung KSC, Tang EWH, Li KKW. Conjunctival carriage of sars-cov-2 using serial sampling: risk factors and protective factors. Can J Ophthalmol. 2021;56(5):340–342. doi:10.1016/j.jcjo.2021.01.003.
- Roehrich H, Yuan C, Hou J. Immunohistochemical study of SARS-CoV-2 viral entry factors in the cornea and ocular surface. Cornea. 2020;39(12):1556–1562. doi:10.1097/ICO.0000000000002509.
- Jin YP, Trope GE, El-Defrawy S, Liu EY, Buys YM. Ophthalmology-focused publications and findings on COVID-19: a systematic review. Eur J Ophthalmol. July, 2021;31(4):1677–1687. doi:10.1177/1120672121992949. Epub 2021 Feb 8. PMID: 33557602; PMCID: PMC8369910.
- Almazroa A, Alamri S, Alabdulkader B, Alkozi H, Khan A, Alghamdi W. Ocular transmission and manifestation for coronavirus disease: a systematic review. Int Health. March 2, 2022;14(2):113–121. doi:10.1093/inthealth/ihab028. PMID: 34043796; PMCID: PMC8195065.
- Cao K, Kline B, Han Y, Ying G-S, Wang NL. Current evidence of 2019 novel coronavirus disease (COVID-19) ocular transmission: a systematic review and meta-analysis. Biomed Res Int. 2020;2020:8. Article ID 7605453. doi:10.1155/2020/7605453.
- Chen YY, Yen YF, Huang LY, Chou P. Manifestations and virus detection in the ocular surface of adult COVID-19 patients: a meta-analysis. J Ophthalmol. June 19, 2021;2021:9997631. doi:10.1155/2021/9997631. PMID: 34258053; PMCID: PMC8225454.
- Marando M, Tamburello A, Gianella P, Taylor R, Bernasconi E, Fusi-Schmidhauser T. Diagnostic sensitivity of RT-PCR assays on nasopharyngeal specimens for detection of SARS-CoV-2 infection: a systematic review and meta-analysis. Caspian J Intern Med. 2022;13(Suppl 3):139–147. doi:10.22088/cjim.13.0.139. PMID: 35872685; PMCID: PMC9272971.